| Identification | Back Directory | [Name]
[2,3'-Bipyridine]-4-carboxamide, N-[1-(2-hydroxy-2-methylpropyl)-5-(1-methyl-4-piperidinyl)-1H-benzimidazol-2-yl]-4'-methoxy- | [CAS]
2375470-64-5 | [Synonyms]
EGFR-IN-26
[2,3'-Bipyridine]-4-carboxamide, N-[1-(2-hydroxy-2-methylpropyl)-5-(1-methyl-4-piperidinyl)-1H-benzimidazol-2-yl]-4'-methoxy- | [Molecular Formula]
C29H34N6O3 | [MOL File]
2375470-64-5.mol | [Molecular Weight]
514.62 |
| Hazard Information | Back Directory | [Uses]
EGFR-IN-26 is a EGFR inhibitor extracted from patent WO2019162323A1 compound I-028. EGFR-IN-26 can be used for the research of cancer[1]. | [References]
[1] BOESE D, et, al. New benzimidazole compounds and derivatives as egfr inhibitors. WO2019162323A1. |
|
|